Polyrizon Ltd.
$11.64
▼
-4.66%
2026-04-21 08:52:00
www.polyrizon-biotech.com
NCM: PLRZ
Explore Polyrizon Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$20.34 M
Current Price
$11.64
52W High / Low
$2,235 / $2.88
Stock P/E
—
Book Value
$13.05
Dividend Yield
—
ROCE
-27.56%
ROE
-25.38%
Face Value
—
EPS
$-4.9
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
2
Beta
—
Debt / Equity
—
Current Ratio
29.03
Quick Ratio
29.03
Forward P/E
—
Price / Sales
—
Enterprise Value
$5.3 M
EV / EBITDA
-0.9
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Edgewise Therapeutics, Inc. | $33.97 | — | $3.69 B | — | -36.44% | -34.19% | $35 / $12.15 | $4.92 |
| 2. | CervoMed Inc. | $3.97 | — | $36.76 M | — | -155.27% | -93.92% | $13.13 / $3.51 | $1.97 |
| 3. | IN8bio, Inc. | $1.5 | — | $14.77 M | — | -68.2% | -92.49% | $5.82 / $1.17 | $2.82 |
| 4. | IO Biotech, Inc. | $0.01 | — | $0.55 M | — | -197.41% | -2.4% | $2.79 / $0.01 | $0.01 |
| 5. | Atrium Therapeutics, Inc. | $14.3 | — | $239.4 M | — | -32.47% | -104.92% | $73.06 / $11.95 | $-4.04 |
| 6. | Capricor Therapeutics, Inc. | $34.21 | — | $2.04 B | — | -33.78% | -46.56% | $40.37 / $4.3 | $5.33 |
| 7. | Protagonist Therapeutics, Inc. | $104.42 | — | $6.74 B | — | -25.39% | -20.18% | $107.84 / $41.28 | $9.82 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -5.79 M | -1.3 M | -0.64 M | -0.9 M |
| Net Profit | -3.33 M | -1.54 M | -0.6 M | -0.78 M |
| EPS in Rs | -2.06 | -0.95 | -0.37 | -0.48 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 21.44 M | 5.55 M | 0.56 M | 0.55 M |
| Total Liabilities | 0.44 M | 0.26 M | 0.75 M | 1.45 M |
| Equity | 20.99 M | 5.29 M | -0.19 M | -0.9 M |
| Current Assets | 12.86 M | 2.65 M | 0.05 M | 0.05 M |
| Current Liabilities | 0.44 M | 0.26 M | 0.5 M | 1.2 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -4.53 M | -1.15 M | -0.54 M | -1.13 M |
| Investing CF | -16.53 M | 0.03 M | 0 M | -0 M |
| Financing CF | 19.81 M | 3.67 M | 0.51 M | 0.65 M |
| Free CF | -4.54 M | -1.15 M | -0.54 M | -1.14 M |
| Capex | -0.01 M | — | — | -0 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -115.86% | -157.5% | 22.98% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-11-28 | 1:0.166667 |
| 2025-05-27 | 1:0.004 |